PAC-1
PAC-1 is a procaspase-3 activating compound investigated as an anticancer agent in preclinical research. It has demonstrated efficacy in inducing apoptosis in vitro and inhibiting tumor growth in vivo across various cancer models, including lymphoma, melanoma, breast, and solid tumors.
Product Specifications
CAS Number
315183-21-2
Product Name Alternative
Procaspase activating compound 1, Procaspase activating compound1, Procaspase activating compound-1, Procaspase-3, Apoptosis, Autophagy, Caspase, Inhibitor, PAC 1, PAC1, PAC-1, inhibit
Field of Research
Cell Biology
Purity
>98%
Bioactivity
Procaspase-3 activator
Form
Powder
Solubility
Soluble in DMSO (up to 35 mg/ml) or in Ethanol (up to 15 mg/ml)
Smiles
Oc1c (CC=C) cccc1\C=N\NC (=O) CN1CCN (Cc2ccccc2) CC1
Molecular Formula
C23H28N4O2
Molecular Weight
392.49
Storage Conditions
-20°C
Notes
For research use only.
Other Product Names
4- (Phenylmethyl) -1-piperazineacetic acid [[2-hydroxy-3- (2-propenyl) phenyl]-methylene]hydrazide
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
OR1047449-01 100 mg
2- (1- ((Methylthio) methyl) cyclopropyl) acetic acid
Sign In for Pricing
View Details OR1047449-02 250 mg
2- (1- ((Methylthio) methyl) cyclopropyl) acetic acid
Sign In for Pricing
View Details OR1047449-03 1 g
2- (1- ((Methylthio) methyl) cyclopropyl) acetic acid
Sign In for Pricing
View Details 